ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2021. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,507,366 | +67.6% | 134,827 | -1.1% | 0.00% | 0.0% |
| Q1 2024 | $899,316 | +25.4% | 136,260 | -14.1% | 0.00% | – |
| Q4 2023 | $717,025 | +48.6% | 158,634 | +17.7% | 0.00% | – |
| Q3 2023 | $482,548 | +24.9% | 134,790 | +28.7% | 0.00% | – |
| Q2 2023 | $386,350 | +13.9% | 104,702 | +2.2% | 0.00% | – |
| Q1 2023 | $339,199 | -19.9% | 102,477 | -6.1% | 0.00% | – |
| Q4 2022 | $423,503 | +118.3% | 109,150 | +36.8% | 0.00% | – |
| Q3 2022 | $194,000 | -27.1% | 79,788 | -40.6% | 0.00% | – |
| Q2 2022 | $266,000 | +850.0% | 134,374 | +793.4% | 0.00% | – |
| Q1 2022 | $28,000 | +27.3% | 15,041 | -5.3% | 0.00% | – |
| Q4 2021 | $22,000 | +4.8% | 15,888 | -15.4% | 0.00% | – |
| Q3 2021 | $21,000 | -40.0% | 18,784 | -13.9% | 0.00% | – |
| Q2 2021 | $35,000 | -94.5% | 21,827 | -93.9% | 0.00% | – |
| Q1 2021 | $634,000 | -3.2% | 360,511 | +7.4% | 0.00% | – |
| Q4 2020 | $655,000 | +92.6% | 335,558 | +135.9% | 0.00% | – |
| Q3 2020 | $340,000 | +38.2% | 142,220 | +69.7% | 0.00% | – |
| Q2 2020 | $246,000 | – | 83,792 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 33,169,604 | $53,072,000 | 0.34% |
| Clearline Capital LP | 922,517 | $1,476,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 860,911 | $1,377,000 | 0.16% |
| Prosight Management, LP | 115,100 | $184,000 | 0.12% |
| Banco BTG Pactual S.A. | 92,500 | $148,000 | 0.10% |
| Meridian Wealth Management, LLC | 164,000 | $262,000 | 0.03% |
| Shay Capital LLC | 159,614 | $255,000 | 0.03% |
| Signature Wealth Management Partners, LLC | 10,500 | $17,000 | 0.02% |
| XTX Topco Ltd | 24,881 | $40,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 227,469 | $364,000 | 0.01% |